Cart
0

Apheresis Market by Product (Devices, Disposable & Reagents, and Software), Method (Centrifugation, Membrane Separation, and Selective Adsorption), Procedure (Donor/Automated Apheresis and Therapeutic Apheresis), Component {Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis), Lymphocytes (Lymph Apheresis), and RBCs (Erythropheresis)}, and End User (Blood Centers, Hospitals, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_182855
Pages: 290
Apr 2018 | 2443 Views
 
Author's : Tanvi Sapatnekar & Garima Chandra
Tables: 168
Charts: 66
 

Apheresis Market Overview:

The global apheresis market was valued at $2,560.4 million in 2016 and is expected to reach $4,200.6 million by 2023, registering a CAGR of 7.3% from 2017 to 2023. Apheresis is a process through which one or more blood components can be obtained by processing of blood using an apheresis system. The remaining components are then returned to the donor or patient either during the process or at the end of the process. The key factors that boost the growth of the global apheresis market include upsurge in demand for blood components across the globe and increase in government initiatives towards blood donation. In addition, newly approved indications for apheresis treatment such as acute disseminated encephalomyelitis, autoimmune hemolytic anemia, and cardiac neonatal lupus supplement the market growth. However, dearth of skilled professionals and complications associated with the apheresis procedure are expected to hamper the market growth. Conversely, rise in demand for plasma-derived pharmaceuticals offer profitable opportunities for the expansion of the market.

by product

Get more information on this report : Request Sample Pages

Product segment review

Based on product, the apheresis market is divided into devices, disposable & reagents, and software. Disposables & reagents generated the highest revenue in 2016, and is anticipated to maintain its dominance throughout the forecast period. In addition, disposable segment is estimated to register the highest growth rate from 2017 to 2023, owing to extensive advancements that are taking place in the manufacturing of blood bags, tubing, and disposable kits. Disposables kits, which include filters, separators, tubing set, blood bags, and other disposables, are utilized on a large scale during processing of the blood. Other disposables include anticoagulants, reagents, and small components associated with the tubing assemblies.

by method
Get more information on this report : Request Sample Pages

Method segment review

On the basis of method, the apheresis market is fragmented into centrifugation, membrane separation, and selective adsorption. The centrifugation method is further categorized into intermittent flow centrifugation and continuous flow centrifugation. Centrifugation method accounted for the highest revenue in 2016, and is expected to maintain its dominance throughout the forecast period. This is attributed to the predominant use of centrifugation in the preparation of blood components such as packed red blood cells (PRBCs) and fresh frozen plasma (FFP) in a single-step heavy spin. Membrane separation is anticipated to register the highest CAGR during the forecast period, as membrane filters play a pivotal role in filtration of plasma from other cellular components to achieve specific cell separation.


by geography

Get more information on this report : Request Sample Pages

Geography segment review

Region wise, the apheresis market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2016, accounting for highest share, and is anticipated to maintain this trend throughout the forecast period. However, Asia-Pacific is projected to register the highest growth rate from 2017 to 2023. The report provides a comprehensive analysis of the key players operating in the global apheresis market such as Haemonetics Corporation, Fresenius Kabi, Terumo BCT, Inc., Asahi Kasei Medical Co., Ltd., HemaCare Corporation, Kaneka Corporation, Kawasumi Laboratories Inc., Cerus Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd.

Key Benefits

  • The study provides an in-depth analysis with the current trends and future estimations of the global apheresis market to elucidate the imminent investment pockets.
  • Comprehensive analysis of the factors that drive and restrict the market growth is provided.
  • The quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of key segments of the industry is provided to understand the products of apheresis used globally.
  • Key players and their strategies are analyzed to understand the competitive outlook of the market.

Apheresis Market Key Segments:

By Product

  • Devices
  • Disposable & Reagents
  • Software

By Method

  • Centrifugation
    • Intermittent Flow Centrifugation
    • Continuous Flow Centrifugation
  • Membrane Separation
  • Selective Adsorption

By Procedure

  • Donor/Automated Apheresis
  • Therapeutic Apheresis
    • Type
      • Plasma Exchange
      • Stem Cell Harvest
      • Photopheresis
      • Low Density Lipid Removal
      • Other Procedures
    • Application
      • Hematology
      • Neurology
      • Oncology
      • Others

By Component

  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis)
  • Lymphocytes (Lymph Apheresis)
  • RBC's (Erythropheresis)

By End User

  • Blood Centers
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Turkey
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Porters five forces analysis
3.4. Market share analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Soaring demand for blood components across the globe
3.5.1.2. Increase in the government initiatives regarding blood donation
3.5.1.3. Newly approved indications for apheresis treatment

3.5.2. Restraints

3.5.2.1. Dearth of skilled professionals
3.5.2.2. Complications associated with the apheresis procedure

3.5.3. Opportunity

3.5.3.1. Rise in the demand for plasma-derived pharmaceuticals

Chapter: 4: APHERESIS MARKET BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Devices

4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Disposables & Reagents

4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Software

4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

Chapter: 5: APHERESIS MARKET BY PROCEDURE

5.1. Overview

5.1.1. Market size and forecast

5.2. Donor/Automated Apheresis

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Therapeutic Apheresis

5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.3.3. Therapeutic Apheresis Market by Type

5.3.3.1. Market size and forecast
5.3.3.2. Plasma Exchange

5.3.3.2.1. Market size and forecast

5.3.3.3. Stem Cell Harvest

5.3.3.3.1. Market size and forecast

5.3.3.4. Photopheresis

5.3.3.4.1. Market size and forecast

5.3.3.5. Low Density Lipid Removal

5.3.3.5.1. Market size and forecast

5.3.3.6. Other Therapeutic Type

5.3.3.6.1. Market size and forecast

5.3.4. Therapeutic Apheresis Market by Specialty

5.3.4.1. Market size and forecast
5.3.4.2. Hematology

5.3.4.2.1. Market size and forecast

5.3.4.3. Neurology

5.3.4.3.1. Market size and forecast

5.3.4.4. Oncology

5.3.4.4.1. Market size and forecast

5.3.4.5. Other Therapeutic Application

5.3.4.5.1. Market size and forecast

Chapter: 6: APHERESIS MARKET BY METHOD

6.1. Overview

6.1.1. Market size and forecast

6.2. Centrifugation

6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.2.3. Intermittent Flow Centrifugation

6.2.3.1. Market size and forecast

6.2.4. Continuous Flow Centrifugation

6.2.4.1. Market size and forecast

6.3. Membrane Separation

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Selective Adsorption

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

Chapter: 7: APHERESIS MARKET BY COMPONENT

7.1. Overview

7.1.1. Market size and forecast

7.2. Plasma (Plasmapheresis)

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Platelets (Plateletpheresis)

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Leukocytes (Leukapheresis)

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

7.5. Lymphocytes (Lymph apheresis)

7.5.1. Market size and forecast
7.5.2. Market analysis, by country

7.6. RBC's (Erythropheresis)

7.6.1. Market size and forecast
7.6.2. Market analysis, by country

Chapter: 8: APHERESIS MARKET BY END USER

8.1. Overview

8.1.1. Market size and forecast

8.2. Blood Centers

8.2.1. Market size and forecast
8.2.2. Market analysis, by country

8.3. Hospitals

8.3.1. Market size and forecast
8.3.2. Market analysis, by country

8.4. Other end users

8.4.1. Market size and forecast
8.4.2. Market analysis, by country

Chapter: 9: APHERESIS MARKET BY REGION

9.1. Overview

9.1.1. Market size and forecast

9.2. North America

9.2.1. Key trends and opportunities
9.2.2. North America market size & forecast by country
9.2.3. North America market size & forecast by product
9.2.4. North America market size & forecast by method
9.2.5. North America market size & forecast by procedure
9.2.6. North America market size & forecast by component
9.2.7. North America market size & forecast by end user

9.2.7.1. U.S. market size & forecast by product
9.2.7.2. U.S. market size & forecast by method
9.2.7.3. U.S. market size & forecast by procedure
9.2.7.4. U.S. market size & forecast by component
9.2.7.5. U.S. market size & forecast by end user
9.2.7.6. Canada market size & forecast by product
9.2.7.7. Canada market size & forecast by method
9.2.7.8. Canada market size & forecast by procedure
9.2.7.9. Canada market size & forecast by component
9.2.7.10. Canada market size & forecast by end user
9.2.7.11. Mexico market size & forecast by product
9.2.7.12. Mexico market size & forecast by method
9.2.7.13. Mexico market size & forecast by procedure
9.2.7.14. Mexico market size & forecast by component
9.2.7.15. Mexico market size & forecast by end user

9.3. Europe

9.3.1. Key trends and opportunities
9.3.2. Europe market size & forecast for apheresis market by country
9.3.3. Europe market size & forecast by product
9.3.4. Europe market size & forecast by method
9.3.5. Europe market size & forecast by procedure
9.3.6. Europe market size & forecast by component
9.3.7. Europe market size & forecast by end user

9.3.7.1. Germany market size & forecast by product
9.3.7.2. Germany market size & forecast by method
9.3.7.3. Germany market size & forecast by procedure
9.3.7.4. Germany market size & forecast by component
9.3.7.5. Germany market size & forecast by end user
9.3.7.6. France market size & forecast by product
9.3.7.7. France market size & forecast by method
9.3.7.8. France market size & forecast by procedure
9.3.7.9. France market size & forecast by component
9.3.7.10. France market size & forecast by end user
9.3.7.11. UK market size & forecast by product
9.3.7.12. UK market size & forecast by method
9.3.7.13. UK market size & forecast by procedure
9.3.7.14. UK market size & forecast by component
9.3.7.15. UK market size & forecast by end user
9.3.7.16. Italy market size & forecast by product
9.3.7.17. Italy market size & forecast by method
9.3.7.18. Italy market size & forecast by procedure
9.3.7.19. Italy market size & forecast by component
9.3.7.20. Italy market size & forecast by end user
9.3.7.21. Spain market size & forecast by product
9.3.7.22. Spain market size & forecast by method
9.3.7.23. Spain market size & forecast by procedure
9.3.7.24. Spain market size & forecast by component
9.3.7.25. Spain market size & forecast by end user
9.3.7.26. Rest of Europe market size & forecast by product
9.3.7.27. Rest of Europe market size & forecast by method
9.3.7.28. Rest of Europe market size & forecast by procedure
9.3.7.29. Rest of Europe market size & forecast by component
9.3.7.30. Rest of Europe market size & forecast by end user

9.4. Asia-Pacific

9.4.1. Key trends and opportunities
9.4.2. Asia-Pacific market size & forecast by country
9.4.3. Asia-Pacific market size & forecast by product
9.4.4. Asia-Pacific market size & forecast by method
9.4.5. Asia-Pacific market size & forecast by procedure
9.4.6. Asia-Pacific market size & forecast by component
9.4.7. Asia-Pacific market size & forecast by end user

9.4.7.1. Japan market size & forecast by product
9.4.7.2. Japan market size & forecast by method
9.4.7.3. Japan market size & forecast by procedure
9.4.7.4. Japan market size & forecast by component
9.4.7.5. Japan market size & forecast by end user
9.4.7.6. China market size & forecast by product
9.4.7.7. China market size & forecast by method
9.4.7.8. China market size & forecast by procedure
9.4.7.9. China market size & forecast by component
9.4.7.10. China market size & forecast by end user
9.4.7.11. India market size & forecast by product
9.4.7.12. India market size & forecast by method
9.4.7.13. India market size & forecast by procedure
9.4.7.14. India market size & forecast by component
9.4.7.15. India market size & forecast by end user
9.4.7.16. Australia market size & forecast by product
9.4.7.17. Australia market size & forecast by method
9.4.7.18. Australia market size & forecast by procedure
9.4.7.19. Australia market size & forecast by component
9.4.7.20. Australia market size & forecast by end user
9.4.7.21. Rest of Asia-Pacific market size & forecast by product
9.4.7.22. Rest of Asia-Pacific market size & forecast by method
9.4.7.23. Rest of Asia-Pacific market size & forecast by procedure
9.4.7.24. Rest of Asia-Pacific market size & forecast by component
9.4.7.25. Rest of Asia-Pacific market size & forecast by end user

9.5. LAMEA

9.5.1. Key trends and opportunities
9.5.2. LAMEA market size & forecast by country
9.5.3. LAMEA market size & forecast by product
9.5.4. LAMEA market size & forecast by method
9.5.5. LAMEA market size & forecast by procedure
9.5.6. LAMEA market size & forecast by component
9.5.7. LAMEA market size & forecast by end user

9.5.7.1. Brazil market size & forecast by product
9.5.7.2. Brazil market size & forecast by method
9.5.7.3. Brazil market size & forecast by procedure
9.5.7.4. Brazil market size & forecast by component
9.5.7.5. Brazil market size & forecast by end user
9.5.7.6. South Africa market size & forecast by product
9.5.7.7. South Africa market size & forecast by method
9.5.7.8. South Africa market size & forecast by procedure
9.5.7.9. South Africa market size & forecast by component
9.5.7.10. South Africa market size & forecast by end user
9.5.7.11. Turkey market size & forecast by product
9.5.7.12. Turkey market size & forecast by method
9.5.7.13. Turkey market size & forecast by procedure
9.5.7.14. Turkey market size & forecast by component
9.5.7.15. Turkey market size & forecast by end user
9.5.7.16. Saudi Arabia market size & forecast by product
9.5.7.17. Saudi Arabia market size & forecast by method
9.5.7.18. Saudi Arabia market size & forecast by procedure
9.5.7.19. Saudi Arabia market size & forecast by component
9.5.7.20. Saudi Arabia market size & forecast by end user
9.5.7.21. Rest of LAMEA market size & forecast by product
9.5.7.22. Rest of LAMEA market size & forecast by method
9.5.7.23. Rest of LAMEA market size & forecast by procedure
9.5.7.24. Rest of LAMEA market size & forecast by component
9.5.7.25. Rest of LAMEA market size & forecast by end user

Chapter: 10: COMPANY PROFILE

10.1. Haemonetics Corporation

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Business performance
10.1.5. Key strategic moves and developments

10.2. Fresenius Kabi

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Business performance
10.2.5. Key strategic moves and developments

10.3. Terumo BCT, Inc.

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Business performance
10.3.5. Key strategic moves and developments

10.4. Asahi Kasei Medical Co., Ltd.

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Business performance
10.4.5. Key strategic moves and developments

10.5. HemaCare Corporation

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Business performance
10.5.5. Key strategic moves and developments

10.6. Kaneka Corporation

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Business performance
10.6.5. Key strategic moves and developments

10.7. Kawasumi Laboratories Inc.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Business performance
10.7.5. Key strategic moves and developments

10.8. Cerus Corporation

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Business performance
10.8.5. Key strategic moves and developments

10.9. B. Braun Melsungen AG

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Business performance
10.9.5. Key strategic moves and developments

10.10. Nikkiso Co., Ltd.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Business performance
10.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 01. HAEMONETICS CORPORATION: APHERESIS PRODUCTS
TABLE 02. GLOBAL APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 03. FEW APHERESIS DEVICES IN THE MARKET
TABLE 04. GLOBAL APHERESIS MARKET FOR DEVICES, BY REGION, 2016-2023 ($MILLION)
TABLE 05. GLOBAL APHERESIS MARKET FOR DISPOSABLES & REAGENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 06. GLOBAL APHERESIS MARKET FOR SOFTWARE, BY REGION, 2016-2023 ($MILLION)
TABLE 07. GLOBAL APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 08. GLOBAL DONOR/AUTOMATED APHERESIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 09. GLOBAL THERAPEUTIC APHERESIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL THERAPEUTIC APHERESIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. GLOBAL THERAPEUTIC APHERESIS MARKET, BY SPECIALTY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 13. GLOBAL APHERESIS MARKET FOR CENTRIFUGATION, BY REGION, 2016-2023 ($MILLION)
TABLE 14. INTERMITTENT FLOW CENTRIFUGATION BASED APHERESIS SYSTEMS
TABLE 15. CONTINUOUS FLOW CENTRIFUGATION BASED APHERESIS SYSTEMS
TABLE 16. GLOBAL APHERESIS MARKET FOR MEMBRANE SEPARATION, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL APHERESIS MARKET FOR ADSORPTION COLUMN, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 19. GLOBAL APHERESIS MARKET FOR PLASMA (PLASMAPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL APHERESIS MARKET FOR PLATELETS (PLATELETPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL APHERESIS MARKET FOR LEUKOCYTES (LEUKAPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL APHERESIS MARKET FOR LYMPHOCYTES (LYMPH APHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL APHERESIS MARKET FOR RBC'S (ERYTHROPHERESIS), BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 25. GLOBAL APHERESIS MARKET FOR BLOOD CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL APHERESIS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL APHERESIS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 ($MILLION)
TABLE 28. GLOBAL APHERESIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. U.S. APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 36. U.S. APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 37. U.S. APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 38. U.S. APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 39. U.S. APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 40. CANADA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 41. CANADA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 42. CANADA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 43. CANADA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 44. CANADA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. MEXICO APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 46. MEXICO APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 47. MEXICO APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 48. MEXICO APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 49. MEXICO APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 50. PLATELET PRODUCTION IN THE EUROPEAN COUNTRIES, 2013
TABLE 51. EUROPE APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 52. EUROPE APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 53. EUROPE APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 54. EUROPE APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 55. EUROPE APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 56. EUROPE APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 57. GERMANY APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 58. GERMANY APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 59. GERMANY APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 60. GERMANY APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 61. GERMANY APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 62. FRANCE APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 63. FRANCE APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 64. FRANCE APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 65. FRANCE APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 66. FRANCE APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 67. UK APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 68. UK APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 69. UK APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 70. UK APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 71. UK APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 72. ITALY APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 73. ITALY APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 74. ITALY APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 75. ITALY APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 76. ITALY APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 77. SPAIN APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 78. SPAIN APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 79. SPAIN APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 80. SPAIN APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 81. SPAIN APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 82. REST OF EUROPE APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 83. REST OF EUROPE APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 84. REST OF EUROPE APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 85. REST OF EUROPE APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 86. REST OF EUROPE APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 87. ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 88. ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 89. ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 90. ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 91. ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 92. ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 93. JAPAN APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 94. JAPAN APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 95. JAPAN APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 96. JAPAN APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 97. JAPAN APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 98. CHINA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 99. CHINA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 100. CHINA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 101. CHINA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 102. CHINA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 103. INDIA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 104. INDIA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 105. INDIA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 106. INDIA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 107. INDIA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 108. AUSTRALIA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 109. AUSTRALIA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 110. AUSTRALIA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 111. AUSTRALIA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 112. AUSTRALIA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 113. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 114. REST OF ASIA-PACIFIC APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 115. REST OF ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 116. REST OF ASIA-PACIFIC APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 117. REST OF ASIA-PACIFIC APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 118. LAMEA APHERESIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 119. LAMEA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 120. LAMEA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 121. LAMEA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 122. LAMEA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 123. LAMEA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 124. BRAZIL APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 125. BRAZIL APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 126. BRAZIL APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 127. BRAZIL APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 128. BRAZIL APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 129. SOUTH AFRICA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 130. SOUTH AFRICA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 131. SOUTH AFRICA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 132. SOUTH AFRICA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 133. SOUTH AFRICA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 134. TURKEY APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 135. TURKEY APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 136. TURKEY APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 137. TURKEY APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 138. TURKEY APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 139. SAUDI ARABIA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 140. SAUDI ARABIA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 141. SAUDI ARABIA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 142. SAUDI ARABIA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 143. SAUDI ARABIA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 144. REST OF LAMEA APHERESIS MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 145. REST OF LAMEA APHERESIS MARKET, BY METHOD, 2016-2023 ($MILLION)
TABLE 146. REST OF LAMEA APHERESIS MARKET, BY PROCEDURE, 2016-2023 ($MILLION)
TABLE 147. REST OF LAMEA APHERESIS MARKET, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 148. REST OF LAMEA APHERESIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 149. HAEMONETICS: COMPANY SNAPSHOT
TABLE 150. HAEMONETICS: OPERATING SEGMENTS
TABLE 151. FRESENIUS: COMPANY SNAPSHOT
TABLE 152. FRESENIUS: OPERATING SEGMENTS
TABLE 153. TERUMO: COMPANY SNAPSHOT
TABLE 154. TERUMO: OPERATING SEGMENTS
TABLE 155. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 156. ASAHI KASEI: OPERATING SEGMENTS
TABLE 157. HEMACARE: COMPANY SNAPSHOT
TABLE 158. HEMACARE: OPERATING SEGMENTS
TABLE 159. KANEKA: COMPANY SNAPSHOT
TABLE 160. KANEKA: OPERATING SEGMENTS
TABLE 161. KAWASUMI: COMPANY SNAPSHOT
TABLE 162. KAWASUMI: OPERATING SEGMENTS
TABLE 163. CERUS: COMPANY SNAPSHOT
TABLE 164. CERUS: OPERATING SEGMENTS
TABLE 165. B. BRAUN: COMPANY SNAPSHOT
TABLE 166. B. BRAUN: OPERATING SEGMENTS
TABLE 167. NIKKISO: COMPANY SNAPSHOT
TABLE 168. NIKKISO: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01. SEGMENTATION OF APHERESIS MARKET
FIGURE 02. TOP INVESTMENT POCKETS IN APHERESIS MARKET, 2016
FIGURE 03. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04. HIGH BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE THREAT OF SUBSTITUTION
FIGURE 06. HIGH THREAT OF NEW ENTRANT
FIGURE 07. HIGH COMPETITIVE RIVALRY
FIGURE 08. MARKET SHARE ANALYSIS, 2016
FIGURE 09. RESTRAINTS, DRIVERS, AND OPPORTUNITY: GLOBAL APHERESIS MARKET
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR DEVICES, BY COUNTRY, 2016 & 2023 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR DISPOSABLES & REAGENTS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR SOFTWARE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF DONOR/AUTOMATED APHERESIS MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF THERAPEUTIC APHERESIS MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL STEM CELL HARVEST MARKET, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL PHOTOPHERESIS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL LOW-DENSITY LIPID REMOVAL MARKET, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL OTHER THERAPEUTIC TYPE MARKET, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL THERAPEUTIC APHERESIS MARKET FOR HEMATOLOGY, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL THERAPEUTIC APHERESIS MARKET FOR NEUROLOGY, 2016-2023 ($MILLION)
FIGURE 22. GLOBAL THERAPEUTIC APHERESIS MARKET FOR ONCOLOGY, 2016-2023 ($MILLION)
FIGURE 23. GLOBAL APHERESIS MARKET FOR OTHER THERAPEUTIC APPLICATION, 2016-2023 ($MILLION)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR CENTRIFUGATION, BY COUNTRY, 2016 & 2023 (%)
FIGURE 25. GLOBAL APHERESIS MARKET FOR INTERMITTENT FLOW CENTRIFUGATION, 2016-2023 ($MILLION)
FIGURE 26. GLOBAL APHERESIS MARKET FOR CONTINUOUS FLOW CENTRIFUGATION, 2016-2023 ($MILLION)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR MEMBRANE SEPARATION, BY COUNTRY, 2016 & 2023 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR SELECTIVE ADSORPTION, BY COUNTRY, 2016 & 2023 (%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR PLASMA (PLASMAPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR PLATELETS (PLATELETPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR LEUKOCYTES (LEUKAPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR LYMPHOCYTES (LYMPH APHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR RBC'S (ERYTHROPHERESIS), BY COUNTRY, 2016 & 2023 (%)
FIGURE 34. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR BLOOD CENTERS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 35. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR HOSPITALS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 36. COMPARATIVE SHARE ANALYSIS OF APHERESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 37. HAEMONETICS: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. HAEMONETICS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. HAEMONETICS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 40. FRESENIUS: NET SALES, 2014-2016 ($MILLION)
FIGURE 41. FRESENIUS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 42. FRESENIUS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 43. TERUMO: NET SALES, 2014-2016 ($MILLION)
FIGURE 44. TERUMO: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 45. TERUMO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 46. ASAHI KASEI: NET SALES, 2014-2016 ($MILLION)
FIGURE 47. ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 48. ASAHI KASEI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 49. HEMACARE: NET SALES, 2014-2016 ($MILLION)
FIGURE 50. HEMACARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 51. HEMACARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 52. KANEKA: NET SALES, 2014-2016 ($MILLION)
FIGURE 53. KANEKA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 54. KANEKA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 55. KAWASUMI: NET SALES, 2014-2016 ($MILLION)
FIGURE 56. KAWASUMI: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 57. KAWASUMI: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 58. CERUS: NET SALES, 2014-2016 ($MILLION)
FIGURE 59. CERUS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 60. CERUS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 61. B. BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 62. B. BRAUN: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 63. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 64. NIKKISO: NET SALES, 2014-2016 ($MILLION)
FIGURE 65. NIKKISO: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 66. NIKKISO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

 

Apheresis involves processing of the whole blood so as to obtain one or more desired blood components. Increase in number of donor apheresis procedures have strongly contributed to the global market growth. Moreover, increase in demand for blood components globally is expected to offer profitable opportunities for the expansion of the market. In addition, therapeutic apheresis is largely carried out among patients suffering from Goodpasture syndrome, preeclampsia, and eclampsia in pregnancy. This has piqued the interest of several companies to manufacture efficient and advanced apheresis systems.

Increase in advancements of the disposables associated with the apheresis procedures has largely contributed in the market revenue in 2016, and is expected to maintain this trend throughout the forecast period. Single-cycle apheresis procedures consume multiple disposable parts, and such intensive consumption of disposables significantly contributes towards the revenue generation. Moreover, single-use products curb the risk of infection, which is of high significance in the apheresis as well as transfusion procedures.

Furthermore, increase in awareness towards blood donations and government initiatives promoting blood donations drive the market growth. Upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Apheresis Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4565
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5160
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $6747
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo